Daniel Martin Net Worth & Insider Trades

Daniel Martin - Chief Commercial Officer, Deciphera Pharmaceuticals, Inc

As of June 21, 2022

What is Daniel Martin's Net Worth?

The current estimated net worth of Deciphera Pharmaceuticals, Inc's Chief Commercial Officer, Daniel Martin, is estimated to be about $2.15M . Daniel Martin owns about 49,521 units of Deciphera Pharmaceuticals, Inc common stock. In the last 4 years at Deciphera Pharmaceuticals, Inc, Daniel Martin has sold an estimated value of $1.94M worth.

What is Daniel Martin's Past Insider Trading?

Daniel Martin's largest purchase order was 26,999 units , worth over $974.66K on January 24, 2020. Daniel Martin's largest sale order was 26,999 units , worth over $1.81M on January 24, 2020. In total, Daniel Martin has made about 8 transactions over 4 years of their time at Deciphera Pharmaceuticals, Inc. Daniel Martin usually trades in September, January and February, with the busiest year in 2022. The most recent transaction was a sale order of 1,311 units , worth over $14.09K on June 21, 2022.

Daniel Martin

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Daniel Martin's Salary in 2020?

As Chief Commercial Officer of Deciphera Pharmaceuticals, Inc, Daniel Martin has a total base salary of $436,800 . Daniel Martin received compensation valued at about $2,640,443 in 2020 after becoming Chief Commercial Officer. The vast majority of their compensation came in the form of stock awards of $386,285 , option awards of $1,546,335 , other earnings, plans or compensations of $247,141 , and other compensation of $23,882 .

What is Daniel Martin's' Mailing Address?

  • Mailing address is C/o Deciphera Pharmaceuticals, Inc. 500 Totten Pond Road Waltham MA 02451 MA

Deciphera Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Steven L. Hoerter 2020 $650,000 - - $6,597,306 $536,250 $11,388 $7,794,944
Steven L. Hoerter 2019 $449,886 - $1,320,800 $6,776,000 $478,500 - $9,025,186
Thomas P. Kelly 2020 $447,200 - $386,285 $1,546,335 $272,278 $7,386 $2,659,484
Thomas P. Kelly 2019 $430,000 - - $1,308,788 $336,690 $11,200 $2,086,678
Thomas P. Kelly 2018 $370,000 - - $1,755,252 $175,000 $11,000 $2,311,252
Matthew L. Sherman, M.D. 2020 $504,986 - $96,571 $385,576 $307,461 $5,962 $1,300,556
Matthew L. Sherman, M.D. 2019 $125,000 $150,000 $1,205,050 $3,458,715 $84,593 $115,164 $5,138,522
Daniel L. Flynn, Ph.D. 2020 $442,000 - $386,285 $1,546,335 $269,112 $11,400 $2,655,132
Daniel C. Martin 2020 $436,800 - $386,285 $1,546,335 $247,141 $23,882 $2,640,443
Daniel C. Martin 2019 $420,000 - - $907,426 $253,344 $505,549 $2,086,319
Daniel C. Martin 2018 $117,875 $100,000 $722,000 $2,189,097 $45,000 $702 $3,174,674
Stephen B. Ruddy, Ph.D. 2020 $383,400 - $386,285 $1,546,335 $216,928 $1,212 $2,534,160
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415121000007/dcph-2021xproxystatement.htm

What are Deciphera Pharmaceuticals, Inc's Past Insider Trades?

Deciphera Pharmaceuticals, Inc's most recent insider trade came on October 5, 2022 by Matthew Sherman who sold 2,587 units worth $48.45K . In the last 5 years, insiders at Deciphera Pharmaceuticals, Inc have sold an estimated value of $102.45M and bought an estimated value of $33.3M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Douglas Michael Taylor, Director,  Patrick Thomas Kelly, Chief Financial Officer,  and Arthur James Bristol, Director .

Deciphera Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1